title: Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis.
abstract: Epithelial cell differentiation was evaluated in 15 samples of duct-acinar dysplasia, a putative premalignant lesion of the prostate, through immunohistochemical staining for five differentiation markers. Prostate-specific antigen (PSA), prostatic acid phosphatase (PAP), Leu-7, pepsinogen II (PG II), and tissue plasminogen activator (t-PA) are all constituents of seminal fluid that are produced by prostatic epithelium. Dysplasia foci were classified into three grades of severity and their locations mapped by camera lucida drawings of each slide. The degree of abnormal staining with each antibody was recorded on the map, and its correlation with dysplasia grade was evaluated. PSA, PAP, and Leu-7 staining were reduced in dysplasia and often absent in severe dysplasia, indicating that reduced differentiation is an early change in prostatic carcinogenesis. PG II and t-PA stains were sometimes positive in a region where they are usually absent, suggesting that deregulation of differentiation markers may accompany reduction in differentiation in these preneoplastic lesions.
authors: Division of Urology, Stanford University Medical Center, California 94305-5118.
authors: J E
authors: JE
authors: McNeal
authors: J
authors: J
authors: Alroy
authors: I
authors: I
authors: Leav
authors: E A
authors: EA
authors: Redwine
authors: F S
authors: FS
authors: Freiha
authors: T A
authors: TA
authors: Stamey
mesh_terms: D000135:Acid Phosphatase / Q000032:analysis; D000906:Antibodies; D000943:Antigens, Differentiation / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D002454:Cell Differentiation; D006801:Humans; D007120:Immunochemistry; D008297:Male; D010435:Pepsinogens / Q000032:analysis; D011230:Precancerous Conditions / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D011467:Prostate / Q000201:enzymology; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D010959:Tissue Plasminogen Activator / Q000032:analysis
chemical_list: D000906:Antibodies; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D010435:Pepsinogens; D000135:Acid Phosphatase; D010959:Tissue Plasminogen Activator; D017430:Prostate-Specific Antigen